$ONCY News Article - Oncolytics Biotech Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer https://marketwirenews.com/news-releases/onco...60711.html
(0)
(0)
Oncolytics Biotech Inc. (ONCY) Stock Research Links